Rising Leaders Alles And Fouse Join Celgene Board
This article was originally published in Scrip
Celgene Corporation has appointed soon-to-be CEO Mark Alles and soon-to-be president and COO Jacqualyn Fouse to its board of directors. Alles has been with Celgene since 2004 and most recently was president and chief operating officer (COO). Celgene has previously announced his promotion to CEO: he will take over from Robert Hugin on March 1, 2016. Prior to being Celgene's president and COO, Alles led the company's hematology and oncology franchise. Currently president of the hematology and oncology franchise, Fouse has been with Celgene since 2010 and was previously Celgene's chief financial officer. Fouse will be promoted to president and COO – effective March 1, 2016.
Register for our free email digests: